Evofem Biosciences Inc banner
E

Evofem Biosciences Inc
F:1AQ1

Watchlist Manager
Evofem Biosciences Inc
F:1AQ1
Watchlist
Price: 0.1432 EUR -2.59%
Market Cap: €65.8m

Profitability Summary

Evofem Biosciences Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Evofem Biosciences Inc

Margins Comparison
Evofem Biosciences Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Evofem Biosciences Inc
F:1AQ1
65.8m EUR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
951.3B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
595.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
285.2B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
243.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
232.2B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.5B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.5B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Evofem Biosciences Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Evofem Biosciences Inc
F:1AQ1
65.8m EUR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
951.3B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
595.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
285.2B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
243.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
232.2B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.5B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.5B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Evofem Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett